Rare diseases
Investigational molecules
Locations
290 conditions with trials, the busiest first
1 641 trials across Europe, recruiting first
Study on Frexalimab for Patients with Relapsing Multiple Sclerosis
BulgariaStudy on Sirolimus for Adults with Facial Skin Sarcoidosis: Evaluating Treatment for Moderate to Severe Cases
FranceStudy of Hydroxychloroquine Safety and Effectiveness in Patients with Early Systemic Sclerosis
ItalyStudy of Rilpivirine for Children and Teens with HIV-1 from Previous Rilpivirine Studies
ItalyStudy of IMC-M113V for Patients with Chronic HIV Infection Who Are Virologically Suppressed
BelgiumStudy on the Effectiveness and Safety of 0.1% Mometasone Furoate Emulsion and Ecural Cream for Adults with Plaque Psoriasis
PolandStudy on Prednisone and Antihistamine for Treating Acute Urticaria in Adults at the Emergency Department
FranceStudy Comparing Methylprednisolone Aceponate Ointment and a Drug Combination for Patients with Mild to Moderate Atopic Dermatitis
GermanyStudy on the Effectiveness and Safety of Guselkumab for Patients with Fistulizing Perianal Crohn's Disease
BelgiumStudy on the Effects and Safety of Efgartigimod PH20 SC for Adults with Active Idiopathic Inflammatory Myopathy
AustriaStudy on NTLA-2001 for Patients with Hereditary Transthyretin Amyloidosis with Polyneuropathy
FranceStudy on Clemastine and Fampridine for Patients with Multiple Sclerosis and Internuclear Ophthalmoparesis
The NetherlandsThe therapies tested most often in Immune system disorders trials.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
